Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP621048.RAtzxX8dxmzBSA2FH0mMO5fTsR92jbNCQdPWXlC-ygnsc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP621048.RAtzxX8dxmzBSA2FH0mMO5fTsR92jbNCQdPWXlC-ygnsc130_assertion type Assertion NP621048.RAtzxX8dxmzBSA2FH0mMO5fTsR92jbNCQdPWXlC-ygnsc130_head.
- NP621048.RAtzxX8dxmzBSA2FH0mMO5fTsR92jbNCQdPWXlC-ygnsc130_assertion description "[We identified the mechanism involved in ATO action on B-CLL cells and show that the combination of low doses of ATO and PI3K inhibitors efficiently induces B-CLL cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621048.RAtzxX8dxmzBSA2FH0mMO5fTsR92jbNCQdPWXlC-ygnsc130_provenance.
- NP621048.RAtzxX8dxmzBSA2FH0mMO5fTsR92jbNCQdPWXlC-ygnsc130_assertion evidence source_evidence_literature NP621048.RAtzxX8dxmzBSA2FH0mMO5fTsR92jbNCQdPWXlC-ygnsc130_provenance.
- NP621048.RAtzxX8dxmzBSA2FH0mMO5fTsR92jbNCQdPWXlC-ygnsc130_assertion SIO_000772 20534739 NP621048.RAtzxX8dxmzBSA2FH0mMO5fTsR92jbNCQdPWXlC-ygnsc130_provenance.
- NP621048.RAtzxX8dxmzBSA2FH0mMO5fTsR92jbNCQdPWXlC-ygnsc130_assertion wasDerivedFrom befree-20150227 NP621048.RAtzxX8dxmzBSA2FH0mMO5fTsR92jbNCQdPWXlC-ygnsc130_provenance.
- NP621048.RAtzxX8dxmzBSA2FH0mMO5fTsR92jbNCQdPWXlC-ygnsc130_assertion wasGeneratedBy ECO_0000203 NP621048.RAtzxX8dxmzBSA2FH0mMO5fTsR92jbNCQdPWXlC-ygnsc130_provenance.